GGB is committed to providing updated news and analysis on our weekly news site, GGBNews.com.

GPI Chief Charlier to Retire

Wed, Sep 9, 2009

Gaming Partners International Corporation announced that President and Chief Executive Officer Gerard P. Charlier will retire effective September 12. He will be replaced by Gregory Gronau, the former CEO of Class II supplier Cadillac Jack who was hired last October as executive vice president and chief operating officer and
was brought in specifically to be groomed as Charlier’s successor after the CEO’s planned retirement.

Charlier was the first CEO of GPI, named to head the combined company after it was formed through the combination of former table game suppliers Bourgogne et Grasset (B&G), Paulson and the Bud Jones Company. He was president and CEO of founding company B&G, and had served on that company’s board since 1985.

“GPI has been my life’s work for so long, and while I will miss the day-to-day activity, I am very confident in handing the reins over to Greg,” said Charlier. “Having worked closely together over the last several months, I know that the experience and commitment that Greg brings to GPI will continue to advance the company as a global leader in table games equipment and technology.”

    Recent Feature Articles

  • Your Friend, Everi

    The supplier’s quest to raise all tides and all boats.

  • Gambling on the Mediterranean

    There are more gaming options in the region than expected, but things are about to change with massive projects planned for Greece and the Emirates

  • Threat or Opportunity?

    Gaming in the metaverse will look different than today’s gaming, but will it add value to the existing gaming companies, attract more players and pass regulatory scrutiny?

  • A Force in Sports Betting

    The third annual Bet Bash was designed by founder Gadoon “Spanky” Kyrollos to make gamblers better at wagering on sports

  • Problem Gambling Treatments Gain Ground

    Problem gambling wasn’t classified as a psychiatric disorder until 1980, but treatments are evolving and becoming more effective